AP Biosciences | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Data insights

13 November 2024

Regeneron keeps up its co-stimulatory crusade

The company’s CD38 x CD28 MAb is among recent clinical trial entrants.

Subscribe to AP Biosciences